| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |